/Medtronic%20Plc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Valued at a market cap of $107.6 billion, Medtronic plc (MDT) develops, manufactures, and sells medical devices and therapies to healthcare systems, physicians, clinicians, and patients. The Galway, Ireland-based company is scheduled to announce its fiscal Q4 earnings for 2026 in the near future.
Before this event, analysts expect this healthcare company to report a profit of $1.58 per share, down 2.5% from $1.62 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $1.36 per share in the previous quarter outpaced the consensus expectations by 2.3%.